Baird Financial Group Inc. Sells 1,376 Shares of Docusign Inc. $DOCU

Baird Financial Group Inc. decreased its holdings in Docusign Inc. (NASDAQ:DOCU) by 10.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,086 shares of the company’s stock after selling 1,376 shares during the quarter. Baird Financial Group Inc.’s holdings in Docusign were worth $984,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Cetera Investment Advisers grew its stake in shares of Docusign by 11.8% during the 4th quarter. Cetera Investment Advisers now owns 50,329 shares of the company’s stock valued at $4,527,000 after acquiring an additional 5,302 shares during the period. CoreCap Advisors LLC grew its stake in shares of Docusign by 113.4% during the 4th quarter. CoreCap Advisors LLC now owns 2,044 shares of the company’s stock valued at $184,000 after acquiring an additional 1,086 shares during the period. Deutsche Bank AG grew its stake in shares of Docusign by 26.3% during the 4th quarter. Deutsche Bank AG now owns 546,078 shares of the company’s stock valued at $49,114,000 after acquiring an additional 113,608 shares during the period. Ethic Inc. bought a new position in shares of Docusign during the 4th quarter valued at approximately $341,000. Finally, Focus Partners Wealth grew its stake in shares of Docusign by 19.8% during the 4th quarter. Focus Partners Wealth now owns 11,063 shares of the company’s stock valued at $995,000 after acquiring an additional 1,829 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at Docusign

In related news, CEO Allan C. Thygesen sold 40,000 shares of the company’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the sale, the chief executive officer directly owned 143,983 shares of the company’s stock, valued at $11,160,122.33. This represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Chatwani sold 22,875 shares of the company’s stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the sale, the insider directly owned 72,126 shares of the company’s stock, valued at approximately $5,394,303.54. This trade represents a 24.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock valued at $5,983,631 in the last ninety days. 1.66% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on DOCU. Argus reissued a “hold” rating on shares of Docusign in a report on Monday. Bank of America boosted their target price on shares of Docusign from $85.00 to $102.00 and gave the stock a “neutral” rating in a report on Friday, September 5th. Morgan Stanley boosted their target price on shares of Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a report on Monday. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Friday, September 5th. Finally, UBS Group set a $95.00 price objective on Docusign in a research note on Friday. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $94.14.

Docusign Stock Down 2.4%

DOCU stock opened at $79.80 on Wednesday. Docusign Inc. has a twelve month low of $54.31 and a twelve month high of $107.86. The stock has a market capitalization of $16.12 billion, a price-to-earnings ratio of 60.00, a price-to-earnings-growth ratio of 4.72 and a beta of 1.02. The firm’s fifty day simple moving average is $75.66 and its two-hundred day simple moving average is $79.29.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. The firm had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities research analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its Board of Directors has initiated a share buyback plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.